肝移植在门静脉高压症治疗中的地位及围手术期处理
作者:
通讯作者:
作者单位:

作者简介:

严律南

基金项目:


Status and perioperative management of liver transplantation in treatment of portal hypertension
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 音频文件
  • |
  • 视频文件
    摘要:

    摘要:
    目的 探讨在肝移植门静脉高压症治疗中的地位以及围手术期处理方法。
    方法 回顾性分析近4年间经肝移植治疗的56例门静脉高压症患者的临床资料,分析并发症的发生率、住院期间的病死率和移植后生存率;观察保留脾脏肝移植术后血小板的变化和彩色Doppler超声监测肝血流的变化。
    结果 56例患者中6例(10.7%)同时行脾切除。术后并发症发生率30.4%,住院期间病死率12.5%,1,2,3年生存率分别为87.46%,85.19%和81.58%。保脾肝移植患者术后3d血小板处于最低值。
    结论 肝移植是目前能从根本上治疗门静脉高压症的有效方法;围手术期处理对手术成功和患者的预后至关重要。

    Abstract:

    Abstract:Objective
    To explore the status and perioperative management of liver transplantation in treatment of portal hypertension.
    Methods Clinical data of 56 patients with portal hypertension who underwent orthotropic liver transplantation (OLT) from February 2000 to April 2004 were studied retrospectively.Incidence of complications,and inhospital mortality and survival rate were analyzed. Platelet count after OLT was measured and liver blood flow was monitored by Doppler.
    Results Among the 56 OLT patients, 6 cases(10.7%) underwent simultaneous splenectomy. Incidence of complications was 40.3%,and inhospital mortality and 1-,2-,and 3- year survival rate after OLT were 12.5% and 87.46%,85.19% and 81.58% respectively. Platelet count reached a nadir at posttransplant day 3.
    Conclusions OLT is an effective method for radical treatment of portal hypertension. Perioperative management is of vital importance for success of the operation and patient′s prognosis.

    参考文献
    相似文献
    引证文献
引用本文

谢建国,严律南.肝移植在门静脉高压症治疗中的地位及围手术期处理[J].中国普通外科杂志,2005,14(6):2-.
DOI:10.7659/j. issn.1005-6947.2005.06.002

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2005-01-17
  • 最后修改日期:2005-04-24
  • 录用日期:
  • 在线发布日期: 2005-06-25